Nephros (NEPH) Research & Development (2010 - 2026)
Nephros (NEPH) recorded quarterly Research & Development of $346000.0 in Q1 2026, down 12.41% quarter-over-quarter from $395000.0 in Q4 2025, and up 17.29% on a YoY basis from $295000.0 in Q1 2025.
Nephros (NEPH) Research & Development (2010 - 2026) Analysis & Trends
Nephros' Research & Development history runs 17 years deep, the most recent figure standing at $346000.0 for Q1 2026.
- In Q1 2026, Research & Development rose 17.29% year-over-year to $346000.0; the TTM figure through Mar 2026 stood at $1.4 million (up 40.55% YoY), while the FY2025 annual figure was $1.3 million, up 47.79% from the prior year.
- Research & Development was $346000.0 for Q1 2026 at Nephros, down from $395000.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $395000.0 in Q4 2025 to a low of $188000.0 in Q3 2024.
- Historically, Research & Development has averaged $277647.1 across 5 years, with a median of $254000.0 in 2024.
- The sharpest annual moves came in 2022 and 2025: Research & Development slumped 43.94% in 2022, then surged 79.79% in 2025.
- A 5-year view of Research & Development shows it stood at $359000.0 in 2022, then slumped by 42.06% to $208000.0 in 2023, then rose by 21.15% to $252000.0 in 2024, then surged by 56.75% to $395000.0 in 2025, then fell by 12.41% to $346000.0 in 2026.
- The last three Research & Development figures came in at $346000.0 (Q1 2026), $395000.0 (Q4 2025), and $338000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 361.90 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 249.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 94.27 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 15.80 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 189.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 42.50 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 98.66 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 139.00 Mn |
| 10 | Nephros | 34.19 Mn | 30.17 Mn | 2.99 Mn | 346,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 346,000.00 |
| Dec 31, 2025 | 395,000.00 |
| Sep 30, 2025 | 338,000.00 |
| Jun 30, 2025 | 311,000.00 |
| Mar 31, 2025 | 295,000.00 |
| Dec 31, 2024 | 252,000.00 |
| Sep 30, 2024 | 188,000.00 |
| Jun 30, 2024 | 254,000.00 |
| Mar 31, 2024 | 212,000.00 |
| Dec 31, 2023 | 208,000.00 |
| Sep 30, 2023 | 205,000.00 |
| Jun 30, 2023 | 221,000.00 |
| Mar 31, 2023 | 239,000.00 |
| Dec 31, 2022 | 359,000.00 |
| Sep 30, 2022 | 252,000.00 |
| Jun 30, 2022 | 273,000.00 |
| Mar 31, 2022 | 372,000.00 |
| Dec 31, 2021 | 328,000.00 |
| Sep 30, 2021 | 395,000.00 |
| Jun 30, 2021 | 487,000.00 |